DAVID LYONS: Open Payments
NPI 1639533243 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 35 payments from 9 companies in 2025. Trend: 2023 $584 · 2024 $513 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $207 |
| ABBVIE INC. | 8 | $151 |
| PFIZER INC. | 4 | $89 |
| Amgen Inc. | 4 | $73 |
| Exact Sciences Corporation | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: BREZTRI, UBRELVY, Cologuard Collection Kit, VRAYLAR, OTEZLA, NURTEC ODT, PREVNAR 20, Jornay PM.
Industry payments across NV — which companies pay providers there.
